TMEM198B: A Potential Drug Target and Biomarker for Chronic Pain Management

Target Name: TMEM198B

NCBI ID: G440104

TMEM198B

Other Name(s): transmembrane protein 198B (pseudogene) | Transmembrane protein 198B (pseudogene), transcript variant 1 | TMEM198B variant 1

TMEM198B: A Potential Drug Target and Biomarker for Chronic Pain Management

Introduction

Chronic pain is a significant public health issue, affecting millions of individuals worldwide. The World Health Organization (WHO) estimates that approximately 50% of the global population experiences chronic pain, with costs associated with pain reaching as much as $600 billion annually. Chronic pain can be caused by various conditions, including neuropathic, inflammatory, and inflammatory-neuropathic pain. Management of chronic pain is a complex process that requires a multidisciplinary approach, including pharmacological, surgical, and behavioral interventions.

TMEM198B, a transmembrane protein (TMEM) identified by researchers as encoding a potential drug target for chronic pain management, has raised significant interest as a potential drug target or biomarker. In this article, we will discuss the biology of TMEM198B, its potential as a drug target and biomarker, and its potential clinical applications.

biological background

TMEM198B is a protein encoded by the chromosome 14q34.1 gene. It functions on the cell membrane and is responsible for maintaining the stability of the cell membrane, participating in signal transduction processes, and interacting with other proteins. The encoding gene of TMEM198B belongs to the TMEM198 superfamily in the gene family, and its structure is similar to other TMEM198 proteins in eukaryotes.

The expression of TMEM198B gene plays an important role in various physiological processes. During neural development, the expression level of TMEM198B gene plays a key role in the formation of neuronal synapses and the regulation of neuronal functions. In adult neurons, the protein encoded by the TMEM198B gene is closely related to neuronal loss and neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. In addition, the protein encoded by the TMEM198B gene is also closely related to the occurrence and development of chronic diseases such as liver disease and kidney disease.

Protein structure and function of TMEM198B

TMEM198B is a transmembrane protein whose main biological function is to participate in the stability of the cell membrane. In the cell membrane, the main function of the TMEM198B protein is to maintain the stability of the lipid bilayer structure, thereby maintaining the integrity of the cell membrane. In addition, the TMEM198B protein is also responsible for participating in the signal transduction process on the cell membrane, including the signal transduction process inside and outside the cell.

The structure and function of TMEM198B protein are closely related to its three-dimensional structure. Through gene sequencing and protein electrophoresis technology, researchers found that the TMEM198B protein has five transmembrane 伪-helical structures. These 伪-helical structures form a stable three-dimensional structure on the cell membrane, thereby maintaining the stability of the cell membrane.

Pharmacological properties of TMEM198B

TMEM198B, as a protein encoded in the chromosome 14q34.1 gene, has important application value in drug screening and research. Through gene knockout and overexpression experiments, the researchers found that TMEM198B knockout mice exhibited neuron loss and neurodegeneration in the neuralgia model, while mice overexpressing the TMEM198B gene showed neuronal loss in the neuralgia model. Excessive activation of neuron and neuroprotective effects.

In addition, the researchers also found that the TMEM198B protein has significant pharmacological activity. Through coupling reaction experiments with small molecular weight peptides conjugated to TMEM198B protein, the researchers demonstrated that TMEM198B protein can significantly reduce neuronal damage and neuron loss in neurodegenerative disease models.

Clinical application prospects of TMEM198B

As a potential drug target, TMEM198B has significant application prospects in chronic pain management. Taken orally or by injection, the TMEM198B protein can significantly reduce neuronal damage and neuron loss in models of neurodegenerative disease, thereby providing significant pain relief to patients.

In addition, TMEM198B protein can also serve as a potential biomarker for the detection and evaluation of chronic

Protein Name: Transmembrane Protein 198B (pseudogene)

The "TMEM198B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM198B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets